United States patent law

Poxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2023

Retrieved on: 
Wednesday, November 8, 2023

Sumitomo Pharma has worked diligently to increase the production and secure inventory capacity to meet this increasing demand.

Key Points: 
  • Sumitomo Pharma has worked diligently to increase the production and secure inventory capacity to meet this increasing demand.
  • For the Sumitomo Pharma FY 2023, as a conservative assumption in line with Sumitomo Pharma’s forecast, Poxel expects to receive 8% royalties on TWYMEEG net sales.
  • On July 5th, Poxel was chosen as the winner of the 2023 edition of the I-nov contest for its program in ALD.
  • Next Financial Press Release: Fourth Quarter 2023 Cash and Revenue update, on February 15, 2024

EXpressLO LLC Awarded U.S. Patent 11,808,679 for Cryo-EM Specimen Handling

Retrieved on: 
Tuesday, November 7, 2023

LEHIGH ACRES, Fla., Nov. 7, 2023 /PRNewswire-PRWeb/ -- EXpressLO LLC was awarded U.S. Patent 11,808,679 from the U.S. Patent and Trademark Office describing highly innovative methods and apparatus for cryo-EXLO manipulation of biological and beam sensitive materials. EXpressLO LLC is the most comprehensive provider of focused ion beam (FIB) ex situ lift out (EXLO) specimen preparation solutions for transmission electron microscopy (EM) and other analytical techniques.

Key Points: 
  • EXpressLO LLC has been awarded U.S. Patent 11,808,679 from the USPTO for a unique cryogenic ex situ lift out specimen manipulation process for cryogenically prepared focused ion beam specimens.
  • LEHIGH ACRES, Fla., Nov. 7, 2023 /PRNewswire-PRWeb/ -- EXpressLO LLC was awarded U.S. Patent 11,808,679 from the U.S. Patent and Trademark Office describing highly innovative methods and apparatus for cryo-EXLO manipulation of biological and beam sensitive materials.
  • EXpressLO LLC is the most comprehensive provider of focused ion beam (FIB) ex situ lift out (EXLO) specimen preparation solutions for transmission electron microscopy (EM) and other analytical techniques.
  • The novel methods and apparatus described in this U.S. patent were invented by EXpressLO LLC founder and President, Dr. Lucille A. Giannuzzi.

EQS-News: EcoGraf Limited: September Quarterly Activities Report

Retrieved on: 
Tuesday, November 7, 2023

Vertically integrated battery anode materials developer EcoGraf Limited (“EcoGraf” or “the Company”) (ASX: EGR) is pleased to release its activities and cash flow reports for the three months ended 30 September 2023.

Key Points: 
  • Vertically integrated battery anode materials developer EcoGraf Limited (“EcoGraf” or “the Company”) (ASX: EGR) is pleased to release its activities and cash flow reports for the three months ended 30 September 2023.
  • VinES, together with VinFast - a global electric vehicle manufacturer, are both members of VinGroup, the largest private conglomerate in Vietnam.
  • Discussions are continuing with battery market participants on the establishment of commercial scale EcoGraf HFfree™ purification facilities in key global battery regions Europe, Asia and North America.
  • EcoGraf is building a vertically integrated battery anode materials business to produce high purity graphite products for the lithium-ion battery and advanced manufacturing markets.

Smartflash sues US Patent Office in ongoing Apple Racketeering Investigation

Retrieved on: 
Monday, October 30, 2023

LONDON, Oct. 30, 2023 /PRNewswire/ -- Patrick Racz, founder, and inventor of Smartflash, has announced a lawsuit filed by Smartflash against the United States Patent and Trademark Office (USPTO) in connection with Smartflash's ongoing Civil RICO investigation into Apple.

Key Points: 
  • LONDON, Oct. 30, 2023 /PRNewswire/ -- Patrick Racz, founder, and inventor of Smartflash, has announced a lawsuit filed by Smartflash against the United States Patent and Trademark Office (USPTO) in connection with Smartflash's ongoing Civil RICO investigation into Apple.
  • In 2015, Racz won a resounding victory against Apple in court, with an initial jury award of $533 million for wilful infringement.
  • The key merits and findings of the case, namely that Apple infringed on the technology and induced others to infringe, remain undisturbed today.
  • For more information or to request an interview contact [email protected] or call Charles Carroll on +44 (0) 20 3176 2700.

Smartflash sues US Patent Office in ongoing Apple Racketeering Investigation

Retrieved on: 
Monday, October 30, 2023

LONDON, Oct. 30, 2023 /PRNewswire/ -- Patrick Racz, founder, and inventor of Smartflash, has announced a lawsuit filed by Smartflash against the United States Patent and Trademark Office (USPTO) in connection with Smartflash's ongoing Civil RICO investigation into Apple.

Key Points: 
  • LONDON, Oct. 30, 2023 /PRNewswire/ -- Patrick Racz, founder, and inventor of Smartflash, has announced a lawsuit filed by Smartflash against the United States Patent and Trademark Office (USPTO) in connection with Smartflash's ongoing Civil RICO investigation into Apple.
  • In 2015, Racz won a resounding victory against Apple in court, with an initial jury award of $533 million for wilful infringement.
  • The key merits and findings of the case, namely that Apple infringed on the technology and induced others to infringe, remain undisturbed today.
  • For more information or to request an interview contact [email protected] or call Charles Carroll on +44 (0) 20 3176 2700.

Industrial 1U PCIe WatchDog Board from Amfeltec’s new PacketShark Family(TM) is in Production

Retrieved on: 
Tuesday, October 24, 2023

STOUFFVILLE, Ontario, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Amfeltec Corporation announced today the release of the smallest watchdog timer on the market to date: the first product of the new PacketShark Product Family(TM), the Industrial 1U x1 PCIe WatchDog Timer is in full production.

Key Points: 
  • STOUFFVILLE, Ontario, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Amfeltec Corporation announced today the release of the smallest watchdog timer on the market to date: the first product of the new PacketShark Product Family(TM), the Industrial 1U x1 PCIe WatchDog Timer is in full production.
  • The PacketShark family’s purpose will be to monitor system operation, but also to facilitate recovery in case of operation-critical disruptions, such as a system crash or a power outage.”
    The 1U PCIe WatchDog Timer board can operate at industrial temperature rates (-40°C to +85°C).
  • The board can generate a system-reset signal to restart an embedded appliance in case of a system crash or overheat.
  • It is held securely inside a PCIe connector via Amfeltec’s PCIe Retainer (US Patent #7,850,475), eliminating the need for any bracket.

Trufacial™ Receives Patent for Innovative Dual-Function Plates Integrated Into Its Handheld Skin Rejuvenation System for Simultaneous Delivery of Specific Skin Perfecting Methods

Retrieved on: 
Wednesday, October 18, 2023

This patent specifically covers Trufacial’s three dual-function plates that are integrated, one at a time, onto the front end, each for a specific skincare procedure.

Key Points: 
  • This patent specifically covers Trufacial’s three dual-function plates that are integrated, one at a time, onto the front end, each for a specific skincare procedure.
  • This novel utility patent optimizes the way Trufacial’s three treatment technologies are delivered to promote smoother, firmer and more toned skin.
  • According to Trufacial co-founder Dr. Mahmoud El-Sherif, “This patent recognizes the pioneering use of dual-function plates that can simultaneously apply two compatible skincare methods, maximizing the skin's response to specific treatments.
  • This patent pending method presents a simple and cost-effective approach for future expansion of the Trufacial system for multiple other applications.

Greenlines Technology Awarded First-ever US Patent for Carbon Credit Generation in the Mobility Sector

Retrieved on: 
Tuesday, October 17, 2023

The landmark patent titled, "Methods and Systems for Conversion of Physical Movements to Carbon Units”, bears the US Patent Number US 11,774,255 B2, signifying the world’s first-ever instance of a process to generate carbon credits being awarded a patent.

Key Points: 
  • The landmark patent titled, "Methods and Systems for Conversion of Physical Movements to Carbon Units”, bears the US Patent Number US 11,774,255 B2, signifying the world’s first-ever instance of a process to generate carbon credits being awarded a patent.
  • “Securing the world’s first carbon credit generation process patent is a pivotal moment for us at Greenlines.
  • Greenlines’ patent empowers mobility aggregators such as trip planning applications, private mobility providers, transit agencies, and more, to incentivize and promote sustainable transportation choices.
  • By merging innovation with sustainability, Greenlines is revolutionizing carbon markets while providing customers in the mobility sector the ability to quantify, recognize, and monetize greenhouse gas emission reductions.

US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix

Retrieved on: 
Friday, October 6, 2023

These claims were filed under US Patent Application No.

Key Points: 
  • These claims were filed under US Patent Application No.
  • 16/671.256 by the Joslin Diabetes Center and this patent is exclusively licensed to Renalytix.
  • KidneyintelX.dkd received Food and Drug Administration de Novo marketing authorization on June 29, 2023.
  • A similar strategy to protect Renalytix’s intellectual property is being pursued in Europe, which also presents a large opportunity for KidneyIntelX expansion.

SpineThera Celebrates Milestone Achievement with 6th Patent Issued by the US Patent and Trademark Office

Retrieved on: 
Thursday, October 5, 2023

11,771,707 provides additional protection for SX600 and complements previously issued U.S. Patent Nos.

Key Points: 
  • 11,771,707 provides additional protection for SX600 and complements previously issued U.S. Patent Nos.
  • The newly granted ‘707’ patent underscores SpineThera’s ongoing dedication to developing novel medical technologies that enhance spinal health and improve patients' quality of life.
  • The invention covered by this patent is a result of years of research and development by SpineThera’s team of skilled scientists, engineers, and medical professionals.
  • This 6th US Patent provides additional depth and breadth to our patent portfolio covering our micro-suspension technology.